edit img

upload photo

edit video

upload video

reposition

Reposition

HealthPro BioVentures, LLC

unclaimed
0
0Reviews
Contact
Favorites
0
0Reviews
Contact
Summary
company sizeCompany size 1-10
New York, New York, United States

HealthPro BioVentures LLC provides strategic advisory and investment banking services to emerging companies in the healthcare and life sciences sectors.

HealthPro BioVentures LLC provides strategic advisory and investment banking services to emerging companies in the healthcare and life sciences sectors. Today’s challenging healthcare market is its sole focus. Its highly experienced staff is comprised of financial professionals from within both the healthcare investment banking and life sciences communities. HealthPro is prepared to play a vital role in helping you secure the financial support and strategic partners that you need to reach your corporate objectives and to maximize your value.

Categories

Investment Banks

Reviews (0)

News (6)

Showing  0 – 0  of 0  reviews
USE FILTERS
Showing  0 – 0  of 0  reviews

Have an opinion to share? Write a review to help others decide

Recent News & Articles

22 Sep, 2022
JPMorgan and Goldman are still top dogs in investment banking but business shrinks significantly in 2022

JPMorgan Chase & Co. and Goldman Sachs Group Inc. were one and two in the rankings in investment bankin...

Source: MarketWatch
14 Sep, 2022
Fintech M&A on the rise as valuations crumble

Recent figures compiled by M&A and corporate finance firm Hampleton Partners show a 46 percent increase...

Source: Finextra
2 Aug, 2022
TD to Expand its U.S. Investment Banking Business and Capabilities with Acquisition of Cowen Inc.

TD Bank Group and Cowen Inc. today announced a definitive agreement for TD to acquire Cowen in an all-...

Source: Cowen
21 Jul, 2022
Tea Leaves and Emerging Economic Trends

Bank stocks are often perceived to be a harbinger of broader economic trends so BankerAdvisor wheeled a...

17 May, 2022
Have M&A Trends Flipped for 2022?

Fewer IPOs, a down market and the specter of recession don’t necessarily equal fewer mergers according ...

21 Apr, 2021
SPACs: End of the Beginning or Beginning of the End?

Almost one-third of startups bought by SPACs in 2021 anticipate slower revenue growth with the SEC ques...